nuclear medicine imaging News
-
Positron Corporation Retains FDA Consulting Firm in Preparation for 510K New Device Application
Niagara Falls, NY – February 17, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is pleased to announce today that the Company has retained Medical Device Academy ”MDA”) as its consultant for the Company’s new PET/CT device 510K ...
-
Fine image, Intelligent service - IDC wonderful debut CMEF
The 77th China International Medical Equipment Fair (CMEF) was held at the National Convention and Exhibition Center in Shanghai from May 15-18, 2017. The exhibition space covered 220 000 sqm. Over 4000 representatives from 28 countries gathered at the CMEF, attracting 400 000 visitors and buyers annually. As a historically listed company in North America, IDC captures the Chinese market with an ...
-
FAPI featured in accolades at annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting
Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the 2022 SNMMI Image of the Year Award and JNM Editors’ Choice Award for Overall Best Article in 2021, respectively. Both use FAPI as the primary indicator and further underscore its potential impact as a novel radiopharmaceutical. Each year, SNMMI chooses an image that best ...
By SOFIE
-
Cancer Targeted Technology Announces Advances with its PSMA-targeted PET Imaging and Radiotherapeutic Agents for Prostate Cancer at Upcoming Conferences
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm, is focusing on small molecules that target pivotal enzyme targets on cancer. CTT’s theranostic program is focused on the development of two drugs, CTT1057 and CTT1403, that respectively diagnose and treat prostate cancer based on targeting the biomarker, Prostate Specific Membrane Antigen (PSMA). PSMA is ...
-
Cairn Diagnostics Delivers Virtual Administration of its Novel 13C-Spirulina Gastric Emptying Breath Test
Cairn Diagnostics, an innovative leader in providing cutting-edge breath tests intended for routine use in diagnostic medicine, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of the Company’s 13C-Spirulina Gastric Emptying Breath Test (GEBT) to now include “at home” administration under virtual supervision of Cairn Diagnostics. GEBT ...
-
Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems
Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America Niagara Falls, NY – January 18, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field ...
-
CTT to Present Data on Prostate Cancer Therapy Candidates at Upcoming Conferences
The most recent performance data on Cancer Targeted Technology’s (CTT) leading drugs, CTT1057 and CTT1403, in prostate cancer clinical and preclinical studies will be presented at several scientific and business meetings in June and one that took place in April, the company announced in a press release. The meetings featuring CTT presentations include the American Society of Clinical ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you